Biocon Biologics eyes $200m, plans IPO in 2 years: Mazumdar-Shaw
It looks to build a pipeline of 28 biosimilars across global markets in three phases.from Markets-Economic Times https://ift.tt/30ThpQ6
It looks to build a pipeline of 28 biosimilars across global markets in three phases.from Markets-Economic Times https://ift.tt/30ThpQ6
Post a Comment